Compounds Useful as RET Inhibitors
US-2025243202-A1 · Jul 31, 2025 · US
This page is not indexed by search engines while we improve data quality.
Sutton Jonathan Mark patents
Sutton Jonathan Mark is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Sutton Jonathan Mark |
| Total patents | 35 |
| First publication | May 5, 2015 |
| Latest publication | Jul 31, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterocyclic Compounds as RET Kinase Inhibitors
US-2025236624-A1 · Jul 24, 2025 · US
Compounds Useful as RET Inhibitors
US-2024132504-A1 · Apr 25, 2024 · US
Heterocyclic Compounds as RET Kinase Inhibitors
US-2024116938-A1 · Apr 11, 2024 · US
Heterocyclic Compounds as RET Kinase Inhibitors
US-2023339954-A1 · Oct 26, 2023 · US
Compounds useful as RET inhibitors
US-11680068-B2 · Jun 20, 2023 · US
Heterocyclic compounds as RET kinase inhibitors
US-11661423-B2 · May 30, 2023 · US
Heterocyclic compounds as RET kinase inhibitors
US-11548896-B2 · Jan 10, 2023 · US
Compounds Useful as RET Inhibitors
US-2022348585-A1 · Nov 3, 2022 · US
Compounds useful as RET inhibitors
US-11352361-B2 · Jun 7, 2022 · US
Recent patents
Latest publications not already listed above.
Heterocyclic Compounds as RET Kinase Inhibitors
US-2021155628-A1 · May 27, 2021 · US
Heterocyclic compounds as ret kinase inhibitors
US-10954241-B2 · Mar 23, 2021 · US
Heterocyclic Compounds as RET Kinase Inhibitors
US-2021047334-A1 · Feb 18, 2021 · US
Heterocyclic compounds as RET kinase inhibitors
US-10844067-B2 · Nov 24, 2020 · US
Compounds Useful as RET Inhibitors
US-2020157107-A1 · May 21, 2020 · US
Heterocyclic compounds as ret kinase inhibitors
US-2019263819-A1 · Aug 29, 2019 · US
Heterocyclic compounds as ret kinase inhibitors
US-2019106425-A1 · Apr 11, 2019 · US
Pyrazolone compounds having human neutrophil elastase inhibitory properties
US-10172830-B2 · Jan 8, 2019 · US
Compounds
US-10023558-B2 · Jul 17, 2018 · US
Pyrimidinone compounds which are HNE inhibitors
US-9868740-B2 · Jan 16, 2018 · US
Novel compounds
US-2018009787-A1 · Jan 11, 2018 · US
Novel compounds
US-2017340611-A1 · Nov 30, 2017 · US
Pyrimidinone compounds as human neutrophil elastase inhibitors
US-9828382-B2 · Nov 28, 2017 · US
Compounds
US-9802919-B1 · Oct 31, 2017 · US
Novel compounds
US-2017101413-A1 · Apr 13, 2017 · US
Compounds
US-9573955-B2 · Feb 21, 2017 · US
Compounds
US-9487528-B2 · Nov 8, 2016 · US
Novel compounds
US-2016251362-A1 · Sep 1, 2016 · US
Compounds
US-9409870-B2 · Aug 9, 2016 · US
Novel compounds
US-2016168101-A1 · Jun 16, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Cancer Research Tech Ltd | 17 |
| Chiesi Farm Spa | 13 |
| Chiesi Farma Spa | 6 |
| Chiese Farm S P A | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D487/04 | 27 |
| A61K31/519 | 19 |
| A61P35/00 | 19 |
| A61P11/00 | 18 |
| C07D471/04 | 15 |